Podcast Episodes
Back to SearchAdvances in stem cell transplantation from EBMT 2026: managing GvHD, donor selection & evolving clinical strategies
Episode 335
This episode reviews major advances presented at the EBMT 2026 meeting in Madrid, covering novel treatments for acute and chronic GVHD, including a p…
5 months, 3 weeks ago
Myeloid Monthly: breaking news & updates from the classification advancement meeting
Episode 334
This VJHemOnc podcast introduces the first edition of Myeloid Monthly, focusing on key developments in myeloid malignancies. Amer Zeidan, MD, Yale Un…
6 months ago
How AI is transforming hematologic oncology
Episode 333
This VJHemOnc podcast explores how artificial intelligence (AI) is transforming hematologic oncology, from clinical research and diagnostics to risk …
6 months, 1 week ago
MRD in ALL and AML: from prognostic marker to clinical endpoint
Episode 332
This VJHemOnc podcast explores the evolving role of measurable residual disease (MRD) in acute myeloid leukemia (AML) and acute lymphoblastic leukemi…
6 months, 2 weeks ago
Nursing in CAR-T & cellular therapy: updates and insights from the EBMT-EHA CAR T-cell Meeting 2026
Episode 329
Nurses play a key role in the CAR T-cell therapy process. In this podcast episode, you will hear insights into nursing in CAR-T and cellular therapy …
7 months, 1 week ago
Recent BTK inhibitor trial updates across non-Hodgkin lymphoma subtypes
Episode 328
Today’s episode of the VJHemOnc podcast features updates from a number of clinical trials exploring BTK inhibitors (BTKi) and BTKi-containing regimen…
7 months, 2 weeks ago
ASH 2025 highlights in AL amyloidosis: risk stratification, bispecific antibodies, CAR-T, & MRD
Episode 327
This VJHemOnc podcast highlights key AL amyloidosis updates from ASH 2025, spanning risk stratification, optimisation of frontline therapy, emerging …
7 months, 4 weeks ago
Top ASH 2025 updates in AML: redefining frontline therapy, menin inhibition, venetoclax-based triplets, & emerging immunotherapies
Episode 326
This VJHemOnc podcast highlights key acute myeloid leukemia (AML) updates from ASH 2025, spanning frontline therapy, molecularly targeted approaches,…
8 months ago
Managing and preventing differentiation syndrome in APL
Episode 324
In this episode of the VJHemOnc Podcast, we focus on the management and prevention of differentiation syndrome in acute promyelocytic leukemia (APL).…
8 months, 1 week ago
Top ASH 2025 NHL updates: novel CAR T-cell therapies, fixed-duration strategies, evolving frontline approaches, & more
Episode 323
This podcast highlights key non-Hodgkin lymphoma (NHL) updates from ASH 2025 across follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), …
8 months, 2 weeks ago